Show simple item record

dc.contributor.authorTamayo-Gómez, Eduardo
dc.contributor.authorGómez, Esther
dc.contributor.authorBustamante, Juan
dc.contributor.authorGómez-Herreras, José Ignacio 
dc.contributor.authorFonteriz, Rosalba
dc.contributor.authorBobillo, Felipe
dc.contributor.authorBermejo-Martín, Jesús F
dc.contributor.authorCastrodeza, Javier
dc.contributor.authorHeredia, María
dc.contributor.authorFierro, Inma
dc.contributor.authorÁlvarez, Francisco Javier
dc.date.accessioned2026-02-19T11:20:58Z
dc.date.available2026-02-19T11:20:58Z
dc.date.issued2012
dc.identifier.citationJ Crit Care, 2012, Aug; 27(4):415.e1-11.es
dc.identifier.issn0883-9441es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/82888
dc.descriptionProducción Científicaes
dc.description.abstractPurpose: The aims were to analyze the temporal evolution of neutrophil apoptosis, to determine the differences in neutrophil apoptosis among 28-day survivors and nonsurvivors, and to evaluate the use of neutrophil apoptosis as a predictor of mortality in patients with septic shock. Materials and Methods: Prospective multicenter observational study carried out between July 2006 and June 2009. The staining solution study included 80 patients with septic shock and 25 healthy volunteers. Neutrophil apoptosis was assessed by fluorescein isothiocyanate (FITC)–conjugated annexin V and aminoactinomycin D staining. Results: The percentage of neutrophil apoptosis was significantly decreased at 24 hours, 5 days, and 12 days after the diagnosis of septic shock (14.8% ± 13.4%, 13.4% ± 8.4%, and 15.4% ± 12.8%, respectively; P b .0001) compared with the control group (37.6% ± 12.8%). The difference in apoptosis between 28-day surviving and nonsurviving patients was nonsignificant (P N .05). The mortality rate at 28 days was 53.7%.The crude hazard ratio for mortality in patients with septic shock did not differ according to the percentage of apoptosis (hazard ratio, 1.006; 95% confidence interval, 0.98-1.03; P = .60). Conclusions: During the first 12 days of septic shock development, the level of neutrophil apoptosis decreases and does not recover normal values. No differences were observed between surviving and nonsurviving patients.es
dc.format.mimetypeapplication/pdfes
dc.language.isospaes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.subject.classificationApoptosises
dc.subject.classificationNeutrophiles
dc.subject.classificationSeptic shockes
dc.subject.classificationMortalityes
dc.subject.classificationSurvivorses
dc.titleEvolution of neutrophil apoptosis in septic shock survivors and nonsurvivorses
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1016/j.jcrc.2011.09.001es
dc.identifier.publicationfirstpage415.e1es
dc.identifier.publicationissue4es
dc.identifier.publicationlastpage415.e11es
dc.identifier.publicationtitleJournal of Critical Carees
dc.identifier.publicationvolume27es
dc.peerreviewedSIes
dc.description.project“Gerencia de Salud, Consejería de Sanidad, Junta de Castilla y Leon” (GRS 143/ A/07) and Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional FEDER, Red de Trastornos Adictivos RD06/0001/0020.es
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record